MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION

The article concerns the assessment of functional condition of cell membranes in a variety of pathological conditions, influence of various physical and chemical factors and pharmacological drugs. Aim. To reveal cytoprotection action of trimetazidine in shortand longterm periods of acute myocardial...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Vasilyev, E. Yu. Maychuk, V. Yu. Vasilyev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2014-12-01
Series:	Российский кардиологический журнал
Subjects:	myocardial infarction trimetazidine cell membrane impulse electrical field preductal mr
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/164
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction
by: T. Yu. Rebrova, et al.
Published: (2009-04-01)

TRIMETAZIDINE MB ROLE IN THE OPTIMISATION OF THE ACUTE CORONARY SYNDROME TREATMENT: EFFECTS ON ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION
by: S. I. Davydov, et al.
Published: (2013-12-01)

Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction
by: Xiaolong Qu, et al.
Published: (2025-01-01)

MYOCARDIAL DAMAGE BIOMARKERS DYNAMICS AFTER EXTRACARDIAC SURGERY IN CORONARY HEART DISEASE PATIENTS TAKING TRIMETAZIDINE MR
by: O. A. Bolshedvorskaya, et al.
Published: (2017-05-01)

TRIMETAZIDINE MR EFFECTS ON THE PARAMETERS OF 24-HOUR ELECTROCARDIOGRAM MONITORING AND HEART RATE VARIABILITY
by: M. V. Novikova, et al.
Published: (2013-10-01)

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results
by: L. V. Kremneva, et al.
Published: (2005-04-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

Myocardial cytoprotectors demonstrate anti-apoptotic effect on vascular endotheliocytes
by: A. I. Inzhutova
Published: (1970-01-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

THE USAGE OF TRIMETAZIDINE AND SULODEXIL TO PREVENT TRANSFORMATION OF A NON-Q MI INTO A Q-MI
by: A. A. Abdullaev, et al.
Published: (2001-10-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

Trimetazidine effects on mitochondria energetic activity
by: S. V. Eliseeva, et al.
Published: (2008-12-01)

Efficacy of trimetazidine for myocardial ischemia-reperfusion injury in rat models: a systematic review and meta-analysis
by: Xiaobin Zhang, et al.
Published: (2025-06-01)

The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
by: V. V. Kalyuzhin, et al.
Published: (2002-03-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Clinical effectiveness of long-term trimetazidine MB therapy in patients with cardio-respiratory disease (the results of an open, prospective multi-centre study)
by: N. M. Kolomoets, et al.
Published: (2009-12-01)

Evaluating the role of trimetazidine in preventing myocardial injury and contrast-induced nephropathy in patients undergoing percutaneous coronary interventions
by: Anshul Jain, et al.
Published: (2025-05-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

HOLTER ECG MONITORING AND TREATMENT EFFECTIVENESS CONTROL IN PATIENTS AFTER MYOCARDIAL INFARCTION
by: U. A. Islamova, et al.
Published: (2010-12-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict
by: Z. Yu. Shakhbiyeva, et al.
Published: (2019-03-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

Clinical characteristics and management of post-myocardial infarction patients with stable angina in the outpatient practice of Ukrainian cardiologists (GO-OD study)
by: O. M. Parkhomenko, et al.
Published: (2025-02-01)

Effects of trimetazidine on oxidant-antioxidant balance and angiogenesis; an in vivo experimental study
by: Fethullah Kayan, et al.
Published: (2025-04-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Clinical effectiveness of trimetazidine as a leading cardiovascular drug with metabolic action
by: A. Yu. Gasparyan, et al.
Published: (2008-08-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
by: E. V. Bochkareva, et al.
Published: (2012-08-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

CORRECTION OF MORPHOFUNCTIONAL DISORDERS IN EXPERIMENTAL PREECLAMPSY BY COMBINED USE OF TRIMETAZIDINE AND PURIFIED MICRONIZED FLAVONOID FRACTION AS WELL AS THEIR COMBINATIONS WITH METHYLAMPSY
by: O. E. Antsiferova, et al.
Published: (2021-03-01)

COMPARATIVE EFFECTIVENESS OF DIFFERENT DRUG COMBINATIONS IN REGARD TO END-POINT INCIDENCE DURING POST-INFARCTION PERIOD
by: R. M. Gafurova, et al.
Published: (2011-08-01)